" class="no-js "lang="en-US"> SAGA Diagnostics - Medtech Alert
Tuesday, July 29, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
SAGA Diagnostics | Pharmtech Focus

SAGA Diagnostics

About SAGA Diagnostics

SAGA Diagnostics

SAGA Diagnostics is a personalised cancer medicine and disease monitoring company focused on molecular genetic analyses of circulating tumor DNA and tissue biopsies.

Related Story

Industry News

 SAGA Diagnostics Enters into Development Agreement with AstraZeneca | Pharmtech Focus

SAGA Diagnostics Enters into Development Agreement with AstraZeneca

November 3 2021

SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology […]

Appointments

 SAGA Diagnostics Appoints Peter Collins as Chief Executive Officer | Pharmtech Focus

SAGA Diagnostics Appoints Peter Collins as Chief Executive Officer

October 7 2021

SAGA Diagnostics AB (“SAGA”), a leading cancer liquid biopsy and genomic testing company, has announced the […]